ArticleMedical oncology (Northwood, London, England)2023

Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.

Chinmay Das et al.PubMed ↗Publisher ↗

No numbers read from the abstract.